Literature DB >> 8276022

Calcium metabolism in the Jansen type of metaphyseal dysplasia.

K Kruse1, C Schütz.   

Abstract

The Jansen type of metaphyseal dysplasia (JMD) is a rare disorder characterized by growth disturbance and progressive metaphyseal changes initially reminiscent of rickets or primary hyperparathyroidism. Seven of the 16 patients described until now presented with hypercalcaemia of unknown origin. We report studies of calcium metabolism in a hypercalcaemic girl with JMD during the first 3 years of life. The patient presented with hypercalcaemia, hypercalciuria, elevated urinary phosphate and cyclic adenosine monophosphate (AMP) excretion as well as increased 1,25-dihydroxyvitamin D concentrations in serum despite suppressed or low normal values of circulating intact parathyroid hormone (PTH) and PTH related peptide (PTHrP). Measurements of biochemical indices of bone turnover indicated increased bone resorption without sufficient compensatory bone formation. The study suggests that the hypercalcaemia in our patient was caused by an unknown factor, which is not PTH or PTHrP, with osteolytic activity and stimulatory effect on the proximal kidney tubule.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8276022     DOI: 10.1007/bf01957529

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  [Not Available].

Authors:  S WEIL
Journal:  Z Orthop Ihre Grenzgeb       Date:  1957

2.  Metaphysial dysostosis; report of a case.

Authors:  J A CAMERON; W B YOUNG; H A SISSONS
Journal:  J Bone Joint Surg Br       Date:  1954-11

3.  Jansen's metaphyseal dysostosis.

Authors:  S L Gordon; L A Varano; A Alandete; M J Maisels
Journal:  Pediatrics       Date:  1976-10       Impact factor: 7.124

4.  Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.

Authors:  K Kruse; U Kracht; K Wohlfart; U Kruse
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

5.  The skull in metaphyseal chondrodysplasia type Jansen.

Authors:  W Holthusen; J F Holt; M Stoeckenius
Journal:  Pediatr Radiol       Date:  1975-06-13

6.  [Metaphysis of the Jansen type. (Description of a case)].

Authors:  E Silva
Journal:  Chir Organi Mov       Date:  1966

7.  Evidence for a novel parathyroid hormone-related protein in fetal lamb parathyroid glands and sheep placenta: comparisons with a similar protein implicated in humoral hypercalcaemia of malignancy.

Authors:  C P Rodda; M Kubota; J A Heath; P R Ebeling; J M Moseley; A D Care; I W Caple; T J Martin
Journal:  J Endocrinol       Date:  1988-05       Impact factor: 4.286

8.  Further clinical and radiological features in metaphyseal chondrodysplasia Jansen type.

Authors:  Z Nazará; A Hernández; E Corona-Rivera; G Vaca; A Panduro; C Martínez-Basalo; J M Cantú
Journal:  Radiology       Date:  1981-09       Impact factor: 11.105

9.  Calcium metabolism in Williams-Beuren syndrome.

Authors:  K Kruse; R Pankau; A Gosch; K Wohlfahrt
Journal:  J Pediatr       Date:  1992-12       Impact factor: 4.406

10.  Murk Jansen's metaphyseal chondrodysplasia with long-term followup.

Authors:  K G Silverthorn; C S Houston; B P Duncan
Journal:  Pediatr Radiol       Date:  1987
View more
  5 in total

Review 1.  The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.

Authors:  L M Calvi; E Schipani
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  Jansen Metaphyseal Chondrodysplasia due to Heterozygous H223R-PTH1R Mutations With or Without Overt Hypercalcemia.

Authors:  Sheela Nampoothiri; Eduardo Fernández-Rebollo; Dhanya Yesodharan; Thomas J Gardella; Eric T Rush; Craig B Langman; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2016-07-13       Impact factor: 5.958

3.  An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.

Authors:  Hiroshi Noda; Jun Guo; Ashok Khatri; Thomas Dean; Monica Reyes; Michael Armanini; Daniel J Brooks; Janaina S Martins; Ernestina Schipani; Mary L Bouxsein; Marie B Demay; John T Potts; Harald Jüppner; Thomas J Gardella
Journal:  J Bone Miner Res       Date:  2019-12-04       Impact factor: 6.741

4.  Progression of Mineral Ion Abnormalities in Patients With Jansen Metaphyseal Chondrodysplasia.

Authors:  Hiroshi Saito; Hiroshi Noda; Philippe Gatault; Detlef Bockenhauer; Kah Yin Loke; Olaf Hiort; Caroline Silve; Erin Sharwood; Regina Matsunaga Martin; Michael J Dillon; David Gillis; Mark Harris; Sudhaker D Rao; Richard M Pauli; Thomas J Gardella; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

5.  Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide.

Authors:  E Schipani; B Lanske; J Hunzelman; A Luz; C S Kovacs; K Lee; A Pirro; H M Kronenberg; H Jüppner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.